8 November 2022FeaturesMuireann Bolger

Sea change: a Q&A with Kathi Vidal

You have always been a proponent of diversity and inclusion. What drove you to make that an area of focus?

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com

More on this story

Regulation & Industry

Exclusive: ‘In the end, I did it my own way’ and became a UPC judge

12 August 2026 Unified Patent Court judge Margot Kokke has had an unconventional and oft-interrupted career as the “trailing spouse” of a diplomat. She talks to Sarah Speight about this and more in the fourth in a series of interviews with women judges at the court.

Pharma

Lilly mounts defence as generics circle Mounjaro and Zepbound

11 August 2026 A litigation campaign against generic drugmakers, including Sandoz, Hikma, and Amenal, raise the stakes in the fight over two of the world’s most lucrative weight loss and diabetes treatments.

Pharma

Reading Stief, Haedicke and Wünsche, with the memory of a decade fought in Germany

10 August 2026 Takanori Abe of Abe & Partners brings the perspective of a lawyer with first-hand experience in the German courtrooms to Pharmaceutical, Biological and Chemical Patents, a valuable resource on case law.

More features

Exclusive: ‘In the end, I did it my own way’ and became a UPC judge

The UPC plugs another gap in its procedural rulebook

USPTO director steps into Sun Pharma’s PTAB-ITC clash

USPTO appoints new acting commissioner for patents

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

Exclusive: ‘Cultural differences are an asset’ at the UPC

WATCH: AI-powered patent prosecution for life sciences innovation

WATCH: Overcoming patent eligibility, patentability, and disclosure requirements in life sciences innovation

Sea change: a Q&A with Kathi Vidal

More on this story

Editor's picks

Editor's picks

More features